Celestica (NYSE:CLS): An Affordable Growth Opportunity
Is It Worth Investing in Celestica (CLS) Based on Wall Street's Bullish Views?
Celestica: When Growth Won't Fund Itself (Rating Upgrade)
The Market and UBS Saw Celestica’s $3 Billion Raise Very Differently. Here’s Who I Think Is Right.
Celestica Could Benefit Massively From Jalapeño Chip Ramps (Rating Upgrade)
Celestica (CLS) Down 12.4% Since Last Earnings Report: Can It Rebound?
Does AI-Focused UBS Upgrade Reshape The Bull Case For Celestica’s (TSX:CLS) Long-Term Earnings Power?
UBS Upgrades Celestica to Buy, Raises Price Target to $430
Is Celestica (CLS) a Buy as Wall Street Analysts Look Optimistic?
Scotiabank Reinstates Sector Outperform on Celestica, Announces $500 Price Target
Celestica (TSX:CLS) Closes $3.45 Billion Equity Raise For AI Infrastructure Growth
Celestica Inc (NYSE:CLS) Combines High Growth and Relative Strength for CAN SLIM Leadership
Celestica Completes Equity Offering
Barclays Maintains Overweight on Celestica, Lowers Price Target to $406
Jim Cramer Reaffirms Buy Stance on Celestica (CLS) 25% Pullback
Celestica shares slide after launching $3 billion equity offering
Celestica Stock Drops After Raising $3 Billion via Equity
Celestica Announces Pricing of Equity Offering
Celestica Announces $3 Billion Equity Offering to Accelerate Growth Across Global AI Infrastructure
3 Reasons Why Growth Investors Shouldn't Overlook Celestica (CLS)
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.